our technology
RNA and DNA carriers from R&D grade to clinical applications
Lentiviral vectors for a stable expression
LentiFlash particles for non-integrative RNA delivery
lentiviral manufacturing platform
A continuum from research to clinical studies
applications of lentiviral technologies
The choice of lentiviral technology depends on your application
Gene editing Gene addition Immunotherapy Stable cell linesnews & events
Stay updated with our latest events and breaking news
News & events
-
GMP lentiviral particle manufacturing facilities to produce gene & cell therapy drugs
22-10-2018While supplying high quality vectors for research and preclinical purpose (through the Vectalys pla … Read more -
Pascale Bouillé, présidente de Flash Therapeutics, décorée de l’insigne de chevalier de la légion d’honneur
01-10-2018Pascale Bouillé, Présidente de Flash Therapeutics, a été décorée de l’insigne de chevalier … Read more -
Upcoming ESGCT 2018 in Lausanne – Switzerland
27-09-2018We are happy to announce that our team will attend the 26th Annual Congress of the ESGCT, which wil … Read more